References
  1. Martyny, J.W. , Arbuckle, S.L. , McCammon, C.S. , Erb, N. ,Van Dyke, M. 2008. Methamphetamine Contamination on Environmental Surfaces Caused by Simulated Smoking of Methamphetamine. J. Chem. Health Safety (2008). doi:10.1016/j.jchas.2008.02.004.
  1. DEA. 2002. Methamphetamine. U.S. Department of Justice, Drug Enforcement Administration. 4 pp. accessed on 1/28/2002 at http://www.usdoj.gov/dea/concern/meth.htm.
  1. Cho, A.K. and Melega, W.P. 2002. Patterns of Methamphetamine Abuse and Their Consequences. J. of Addictive Diseases 21(1) 21 - 34.
  1. Cook, C.E. , Jeffcoat, A.R. , Hill, J.M. , Pugh, D.E. , Patetta, P.K. , Sadler, B.M. , White, W.R. , Perez-Reyes, M. 1993. Pharmacokinetics of Methamphetamine Self-Administered to Human Subjects by Smoking S-(+)-Methamphetamine Hydrochloride. Drug Metabolism and Disposition 21(4) 717 - 723.
  1. Harris, D.S. , Boxenbaum, H. , Everhart, E.T. , Sequeira, G. , Mendelson, J.E. , Jones, R.T. 2003. The bioavailability of intranasal and smoked methamphetamine. Clinical Pharmacology and Therapeutics 74(5)  475 - 486.
  1. PDR. 2003. Desoxyn. Physicians Desk Reference.
  1. Hammon, T.L. , and Susan Griffin. 2007. Support for selection of a methamphetamine cleanup standard in Colorado. Regulatory toxicology and Pharmacology 48(2007) 102 - 114.
  1. Salocks, C. and Kaley, K.B. Technical Support Document:  Toxicity Clandestine Labs: Methamphetamine. Vol 1. , Number 8. Methamphetamine. Cal/EPA. Office of Environmental Health Hazard Assessment. Sacramento, CA . 2003. 10 pp.
  1. Smith, L.M. , LaGasse, L.L. , Derauf, C. , Grant, P. , Shah, R. , Arria, A. , Huestis, M. , Haning, W. , Strauss, A. , Grotta, S. , Liu, J. , Lester, B.M. 2008. The Infant Development, Environment, and Lifestyle Study:  Effects of Prenatal Methamphetamine Exposure, Polydrug Exposure, and Poverty on Intrauterine Growth. Pediatrics 118(3):  1149 - 1156.
  1. Smith, L.M. , LaGasse, L.L. , Derauf, C. , Grant, P. , Shah, R. , Arria, A. , Huestis, M. , Haning, W. , Strauss, A. , Grotta, S. , Fallone, M. , Liu, J. , Lester, B.M. 2008. Prenatal Methamphetamine Use and Neonatal Neurobehavioral Outcome. Neurotoxicol. Teratol. :  30 (1) 20 - 28.
  1. Martyny, J.W. , Arbuckle, S.L. , McCammon, C.S. , Esswein, E.J. , Erb, N. , Van Dyke, M. 2007. Chemical concentrations and contamination associated with clandestine methamphetamine laboratories. Journal of Chemical Health and Safety 113:  1 - 13.
  1. U.S. DOJ. 2002. Children at Risk. Information Bulletin Product #2002-LO424-001. United States Department of Justice. July 2002. 6 pp.
  1. Matteucci, M.J. , Auten, J.D. , Crowley, B. , Combs, D. , and Clark, R.F. 2007. Methamphetamine Exposures in Young Children. Pediatric Emergency Care 23(9) 638 - 640.
  1. Salocks, C. Development of a Reference Dose (RfD) for Methamphetamine. Integrated Risk Assessment Branch, Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Sacramento, CA. 73 pp.

  2. Milkovich L and Van den Berg BJ: Effects of antenatal exposure to anorectic drugs. Am J Obstet Gynecol 129:637-42, 1977.

  3. Heinonen OP et al: Birth Defects and Drugs in Pregnancy. Publishing Sciences Group Inc, Littleton, MA. 1977.

  4. Nora JJ et al: Dextroamphetamine sulfate and human malformations. Lancet 1:570-1, 1967.

  5. Little BB et al: Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 72:541-4, 1988.

  6. Buchi, K. (2008). The Far-reaching Impact of Motherhood and Substance Abuse. Utah Addiction Center Report.  2(6); 6-7.
  7. Hale, T. Medications and Mothers Milk, 12th Edition.  2006. Hale Publishing, Amarillo, TX